Exagen Inc. (XGN) News
Follow Exagen Inc. (XGN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Full Transcript: Exagen Q2 2026 Earnings Call
On Tuesday, Exagen (NASDAQ: XGN ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts
LIVE | Sep 17, 2026, 11:19 AM UTC
L
XGN - Exagen Inc. Reports Second Quarter 2026 Financial Results
XGN - Exagen Inc. Reports Second Quarter 2026 Financial Results
EARNINGS | Aug 04, 2026, 12:01 PM UTC
L
Exagen Raises FY2026 Sales Guidance from $70.000M-$73.000M to $72.000M-$75.000M vs $71.560M Est
Exagen (NASDAQ: XGN ) raises FY2026 sales outlook from $70.000 million-$73.000 million to $72.000 million-$75.000 million vs $71.560 million estimate.
EARNINGS | Aug 04, 2026, 12:01 PM UTC
L
XGN - Exagen Inc. to Participate in Upcoming Investor Conference
XGN - Exagen Inc. to Participate in Upcoming Investor Conference
EQUITY | Jul 28, 2026, 01:00 PM UTC
M
XGN: Roth Initiates Buy
Roth Capital initiates coverage on Exagen with a Buy rating and $8 price target
EQUITY | Jun 25, 2026, 10:28 AM UTC